Health Care & Life Sciences » Biotechnology | Stellar Biotechnologies Inc.

Stellar Biotechnologies Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
545.50
345.40
758.70
1,271.70
228.30
Cost of Goods Sold (COGS) incl. D&A
1,410.70
705.70
840.20
1,127.80
534.50
Gross Income
865.20
360.30
81.60
143.90
306.20
SG&A Expense
2,979.90
4,863.80
4,257.00
5,052.20
4,918.40
EBIT
3,845.10
5,224.10
4,338.60
4,908.40
5,224.60
Unusual Expense
11,116.40
2,435.40
2,131.10
212.00
-
Non Operating Income/Expense
70.80
206.50
653.30
76.80
162.00
Pretax Income
14,885.70
7,808.50
2,806.20
5,018.90
5,029.80
Income Tax
0.80
25.20
36.80
7.20
0.80
Consolidated Net Income
14,886.50
7,833.70
2,843.00
5,026.10
5,030.60
Net Income
14,886.50
7,833.70
2,843.00
5,026.10
5,030.60
Net Income After Extraordinaries
14,886.50
7,833.70
2,843.00
5,026.10
5,030.60
Net Income Available to Common
14,886.50
7,833.70
2,843.00
5,026.10
5,030.60
EPS (Basic)
20.30
7.23
2.52
3.99
3.43
Basic Shares Outstanding
737.30
1,083.20
1,136.70
1,260.90
1,462.50
EPS (Diluted)
20.19
7.23
2.50
3.99
3.44
Diluted Shares Outstanding
737.30
1,083.20
1,136.70
1,260.90
1,462.50
EBITDA
3,720.20
5,077.10
4,179.10
4,758.80
5,045.20
Non-Operating Interest Income
5.00
57.50
54.60
24.60
32.70

About Stellar Biotechnologies

View Profile
Address
332 East Scott Street
Port Hueneme California 93041
United States
Employees -
Website http://www.stellarbiotechnologies.com
Updated 09/14/2018
Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.